2024-04-012025-03-312025-03-31false11891084RJB ANAESTHESIA LIMITED2025-08-04falseiso4217:GBPxbrli:pure118910842024-03-31118910842025-03-31118910842024-04-012025-03-31118910842023-03-31118910842024-03-31118910842023-04-012024-03-3111891084bus:SmallEntities2024-04-012025-03-3111891084bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3111891084bus:FullAccounts2024-04-012025-03-3111891084bus:PrivateLimitedCompanyLtd2024-04-012025-03-3111891084core:WithinOneYear2025-03-3111891084core:AfterOneYear2025-03-3111891084core:WithinOneYear2024-03-3111891084core:AfterOneYear2024-03-3111891084core:ShareCapital2025-03-3111891084core:SharePremium2025-03-3111891084core:RevaluationReserve2025-03-3111891084core:OtherReservesSubtotal2025-03-3111891084core:RetainedEarningsAccumulatedLosses2025-03-3111891084core:ShareCapital2024-03-3111891084core:SharePremium2024-03-3111891084core:RevaluationReserve2024-03-3111891084core:OtherReservesSubtotal2024-03-3111891084core:RetainedEarningsAccumulatedLosses2024-03-3111891084core:LandBuildings2025-03-3111891084core:PlantMachinery2025-03-3111891084core:Vehicles2025-03-3111891084core:FurnitureFittings2025-03-3111891084core:OfficeEquipment2025-03-3111891084core:NetGoodwill2025-03-3111891084core:IntangibleAssetsOtherThanGoodwill2025-03-3111891084core:ListedExchangeTraded2025-03-3111891084core:UnlistedNon-exchangeTraded2025-03-3111891084core:LandBuildings2024-03-3111891084core:PlantMachinery2024-03-3111891084core:Vehicles2024-03-3111891084core:FurnitureFittings2024-03-3111891084core:OfficeEquipment2024-03-3111891084core:NetGoodwill2024-03-3111891084core:IntangibleAssetsOtherThanGoodwill2024-03-3111891084core:ListedExchangeTraded2024-03-3111891084core:UnlistedNon-exchangeTraded2024-03-3111891084core:LandBuildings2024-04-012025-03-3111891084core:PlantMachinery2024-04-012025-03-3111891084core:Vehicles2024-04-012025-03-3111891084core:FurnitureFittings2024-04-012025-03-3111891084core:OfficeEquipment2024-04-012025-03-3111891084core:NetGoodwill2024-04-012025-03-3111891084core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111891084core:ListedExchangeTraded2024-04-012025-03-3111891084core:UnlistedNon-exchangeTraded2024-04-012025-03-3111891084core:MoreThanFiveYears2024-04-012025-03-3111891084core:Non-currentFinancialInstruments2025-03-3111891084core:Non-currentFinancialInstruments2024-03-3111891084dpl:CostSales2024-04-012025-03-3111891084dpl:DistributionCosts2024-04-012025-03-3111891084core:LandBuildings2024-04-012025-03-3111891084core:PlantMachinery2024-04-012025-03-3111891084core:Vehicles2024-04-012025-03-3111891084core:FurnitureFittings2024-04-012025-03-3111891084core:OfficeEquipment2024-04-012025-03-3111891084dpl:AdministrativeExpenses2024-04-012025-03-3111891084core:NetGoodwill2024-04-012025-03-3111891084core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111891084dpl:GroupUndertakings2024-04-012025-03-3111891084dpl:ParticipatingInterests2024-04-012025-03-3111891084dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3111891084core:ListedExchangeTraded2024-04-012025-03-3111891084dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3111891084core:UnlistedNon-exchangeTraded2024-04-012025-03-3111891084dpl:CostSales2023-04-012024-03-3111891084dpl:DistributionCosts2023-04-012024-03-3111891084core:LandBuildings2023-04-012024-03-3111891084core:PlantMachinery2023-04-012024-03-3111891084core:Vehicles2023-04-012024-03-3111891084core:FurnitureFittings2023-04-012024-03-3111891084core:OfficeEquipment2023-04-012024-03-3111891084dpl:AdministrativeExpenses2023-04-012024-03-3111891084core:NetGoodwill2023-04-012024-03-3111891084core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3111891084dpl:GroupUndertakings2023-04-012024-03-3111891084dpl:ParticipatingInterests2023-04-012024-03-3111891084dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3111891084core:ListedExchangeTraded2023-04-012024-03-3111891084dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3111891084core:UnlistedNon-exchangeTraded2023-04-012024-03-3111891084core:NetGoodwill2025-03-3111891084core:IntangibleAssetsOtherThanGoodwill2025-03-3111891084core:LandBuildings2025-03-3111891084core:PlantMachinery2025-03-3111891084core:Vehicles2025-03-3111891084core:FurnitureFittings2025-03-3111891084core:OfficeEquipment2025-03-3111891084core:AfterOneYear2025-03-3111891084core:WithinOneYear2025-03-3111891084core:ListedExchangeTraded2025-03-3111891084core:UnlistedNon-exchangeTraded2025-03-3111891084core:ShareCapital2025-03-3111891084core:SharePremium2025-03-3111891084core:RevaluationReserve2025-03-3111891084core:OtherReservesSubtotal2025-03-3111891084core:RetainedEarningsAccumulatedLosses2025-03-3111891084core:NetGoodwill2024-03-3111891084core:IntangibleAssetsOtherThanGoodwill2024-03-3111891084core:LandBuildings2024-03-3111891084core:PlantMachinery2024-03-3111891084core:Vehicles2024-03-3111891084core:FurnitureFittings2024-03-3111891084core:OfficeEquipment2024-03-3111891084core:AfterOneYear2024-03-3111891084core:WithinOneYear2024-03-3111891084core:ListedExchangeTraded2024-03-3111891084core:UnlistedNon-exchangeTraded2024-03-3111891084core:ShareCapital2024-03-3111891084core:SharePremium2024-03-3111891084core:RevaluationReserve2024-03-3111891084core:OtherReservesSubtotal2024-03-3111891084core:RetainedEarningsAccumulatedLosses2024-03-3111891084core:NetGoodwill2023-03-3111891084core:IntangibleAssetsOtherThanGoodwill2023-03-3111891084core:LandBuildings2023-03-3111891084core:PlantMachinery2023-03-3111891084core:Vehicles2023-03-3111891084core:FurnitureFittings2023-03-3111891084core:OfficeEquipment2023-03-3111891084core:AfterOneYear2023-03-3111891084core:WithinOneYear2023-03-3111891084core:ListedExchangeTraded2023-03-3111891084core:UnlistedNon-exchangeTraded2023-03-3111891084core:ShareCapital2023-03-3111891084core:SharePremium2023-03-3111891084core:RevaluationReserve2023-03-3111891084core:OtherReservesSubtotal2023-03-3111891084core:RetainedEarningsAccumulatedLosses2023-03-3111891084core:AfterOneYear2024-04-012025-03-3111891084core:WithinOneYear2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111891084core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3111891084core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3111891084core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3111891084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3111891084core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3111891084core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3111891084core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3111891084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3111891084core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3111891084core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3111891084core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3111891084core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3111891084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3111891084core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3111891084core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3111891084core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3111891084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3111891084core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3111891084bus:Director12024-04-012025-03-3111891084bus:Director22024-04-012025-03-3111891084core:FurnitureFittingsToolsEquipment2024-03-3111891084core:FurnitureFittingsToolsEquipment2024-04-012025-03-3111891084core:FurnitureFittingsToolsEquipment2025-03-31

RJB ANAESTHESIA LIMITED

Registered Number
11891084
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

RJB ANAESTHESIA LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

BARR, Lucy Marie
BARR, Robert James

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

11891084 (England and Wales)
RJB ANAESTHESIA LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3912438
912438
Current assets
Debtors4-1,079
Cash at bank and on hand35,43612,349
35,43613,428
Creditors amounts falling due within one year5(12,251)(14,192)
Net current assets (liabilities)23,185(764)
Total assets less current liabilities24,097(326)
Net assets24,097(326)
Capital and reserves
Called up share capital150150
Profit and loss account23,947(476)
Shareholders' funds24,097(326)
The financial statements were approved and authorised for issue by the Board of Directors on 4 August 2025, and are signed on its behalf by:
BARR, Robert James
Director
Registered Company No. 11891084
RJB ANAESTHESIA LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings25
Office Equipment50
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Fixtures & fittings

Office Equipment

Total

£££
Cost or valuation
At 01 April 248651,0791,944
Additions143599742
At 31 March 251,0081,6782,686
Depreciation and impairment
At 01 April 244651,0411,506
Charge for year114154268
At 31 March 255791,1951,774
Net book value
At 31 March 25429483912
At 31 March 2440038438
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables-1,079
Total-1,079
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables2,7285,606
Taxation and social security6,5321,200
Other creditors1,7016,186
Accrued liabilities and deferred income1,2901,200
Total12,25114,192